Recent advances in the management of male infertility
- PMID: 40275551
- DOI: 10.4103/aja20257
Recent advances in the management of male infertility
Abstract
Male factor infertility has been rising, which accounts for up to 30% of infertility cases and contributes to 50% of overall cases. The aim of this review is to explore the recent advances that have emerged in the field through a narrative review. A comprehensive literature search was conducted using multiple databases, including the Cochrane Library, PubMed, Scopus, and Web of Science. Gray literature was also reviewed through ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform. The findings were presented narratively to encompass the extensive range of published data on male infertility. Significant strides have been made in the field of male infertility, particularly with biomarkers, shear wave elastography, 3-dimensional (3D) bioprinting, artificial intelligence (AI), and robotic and microsurgical treatment, offering promising avenues for diagnosis and treatment. Continued research and technological innovation are essential to further improve outcomes for patients facing male factor infertility.
Keywords: advancement; male factor infertility; reproductive health.
Copyright ©The Author(s)(2025).
References
-
- Thurston L, Abbara A, Dhillo WS. Investigation and management of subfertility. J Clin Pathol 2019; 72: 579–87.
-
- Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem 2018; 62: 2–10.
-
- Rama N, Lescay H, Raheem O. Male factor infertility: what every OB/GYN should know. Obstet Gynecol Clin North Am 2023; 50: 763–77.
-
- Njagi P, Groot W, Arsenijevic J, Dyer S, Mburu G, et al. Financial costs of assisted reproductive technology for patients in low-and middle-income countries: a systematic review. Hum Reprod Open 2023; 2023: hoad007.
-
- GBD 2021 Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the global burden of disease study 2021. Lancet 2024; 403: 2057–99.
LinkOut - more resources
Full Text Sources
